<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01492764</url>
  </required_header>
  <id_info>
    <org_study_id>AVATAR</org_study_id>
    <nct_id>NCT01492764</nct_id>
  </id_info>
  <brief_title>Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)</brief_title>
  <acronym>AVATAR</acronym>
  <official_title>Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the hypothesis that many human heart rhythm disorders are caused by
      small localized sources, where brief ablation may successfully eliminate the heart rhythm
      disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will enroll patients with documented rapid heart rates from the bottom
      chambers of the heart (ventricular tachyarrhythmias).

      During electrophysiological study, the investigators will map the localized sources of these
      heart rhythm disorders.

        1. The 'active' group will prospectively receive brief ablation at localized sources (Focal
           Impulse and Rotor Modulation, FIRM).

        2. The control group will be a historical cohort who have received traditional ablation for
           this disorder.

      All patients will be followed for up to 1 year to ensure that they have no recurrent
      arrhythmias.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2011</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>reduction in ventricular tachyarrhythmias events</measure>
    <time_frame>3 months</time_frame>
    <description>Using careful clinical monitoring, we will compare the burden of VT/VF after ablation (including FIRM) to the burden preceding ablation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>safety of ventricular basket mapping in patients undergoing ablation</measure>
    <time_frame>1 month</time_frame>
    <description>To assess the incidence of adverse events arising from ablation using basket mapping in the ventricles. These include but are not limited to stroke, systemic thromboembolism, MI or acute coronary syndrome, groin complications, or death.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2</enrollment>
  <condition>Ventricular Tachyarrhythmias</condition>
  <arm_group>
    <arm_group_label>Active Group</arm_group_label>
    <description>This group will receive brief ablation at localized sources (Focal Impulse and Rotor Modulation, FIRM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>This group receives traditional ablation for this disorder</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with documented rapid heart rhythms involving the bottom chambers of the heart.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Documented ventricular tachyarrhythmias.

          2. Undergoing clinically indicated EP study with ablation.

        Exclusion Criteria:

        1. Unwillingness or inability to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjiv Narayan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veterans Affairs San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2011</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventricular Tachyarrhythmia</keyword>
  <keyword>Ablation</keyword>
  <keyword>Electrophysiology</keyword>
  <keyword>Human</keyword>
  <keyword>Mapping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

